Gautheron Jérémie, Gores Gregory J, Rodrigues Cecília M P
Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
J Hepatol. 2020 Aug;73(2):394-408. doi: 10.1016/j.jhep.2020.04.001. Epub 2020 Apr 13.
Regulated cell death is intrinsically associated with inflammatory liver disease and is pivotal in governing outcomes of metabolic liver disease. Different types of cell death may coexist as metabolic liver disease progresses to inflammation, fibrosis, and ultimately cirrhosis. In addition to apoptosis, lytic forms of hepatocellular death, such as necroptosis, pyroptosis and ferroptosis elicit strong inflammatory responses due to cell membrane permeabilisation and release of cellular components, contributing to the recruitment of immune cells and activation of hepatic stellate cells. The control of liver cell death is of fundamental importance and presents novel opportunities for potential therapeutic intervention. This review summarises the underlying mechanism of distinct lytic cell death modes and their commonalities, discusses their relevance to metabolic liver diseases of different aetiologies, and acknowledges the limitations of current knowledge in the field. We focus on the role of hepatocyte necroptosis, pyroptosis and ferroptosis in non-alcoholic fatty liver disease, alcohol-associated liver disease and other metabolic liver disorders, as well as potential therapeutic implications.
程序性细胞死亡与炎症性肝病内在相关,并且在代谢性肝病的转归中起关键作用。随着代谢性肝病进展为炎症、纤维化并最终发展为肝硬化,不同类型的细胞死亡可能同时存在。除凋亡外,肝细胞溶解性死亡形式,如坏死性凋亡、焦亡和铁死亡,由于细胞膜通透性增加和细胞成分释放,会引发强烈的炎症反应,促进免疫细胞募集和肝星状细胞激活。控制肝细胞死亡至关重要,并为潜在的治疗干预提供了新的机会。本综述总结了不同溶解性细胞死亡模式的潜在机制及其共性,讨论了它们与不同病因的代谢性肝病的相关性,并认识到该领域当前知识的局限性。我们重点关注肝细胞坏死性凋亡、焦亡和铁死亡在非酒精性脂肪性肝病、酒精性肝病和其他代谢性肝病中的作用,以及潜在的治疗意义。